AI Summary
This article focuses on the development and characterization of a peptide-bisphosphonate nanoparticle for treating breast cancer. The research likely involves creating a targeted nanoparticle delivery system that combines a peptide and bisphosphonate to effectively deliver therapeutic drugs to breast cancer cells. The significance lies in the potential improvement of treatment efficacy and reduced side effects for breast cancer patients.
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.4c00299